VHA breast cancer molecular testing BPA

Ended Awarded Last action

Contract number
36C10X24A0011
Awardee
Awarding agency
Task orders
2 $1,920,402 obligated

Award facts

Opportunity
Combined order value
$1,920,402 Current and potential, with all options
Last date to order 100% complete
Maximum order
$100,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
NAICS code
621511 Medical Laboratories
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) to Exact Sciences Corporation, a medical technology company specializing in cancer diagnostic testing services. The BPA has a ceiling value of $497,370.24 and a period of performance through August 31, 2025. Under this contract, Exact Sciences Laboratories, LLC, a division of Exact Sciences Corporation, will provide medical laboratory testing and analysis services, including gene expression profiling, genomic testing, and related testing kits and laboratory services. The primary focus is on VHA Breast Cancer Molecular Testing, utilizing Exact Sciences' existing Multiple Award Schedule contract for Medical Laboratory Testing and Analysis Services (FSS-621-II). This sole-source BPA was awarded based on the unique and highly specialized nature of the Oncotype DX Breast Cancer Assay, which is only offered by Exact Sciences Corporation. The agency has determined that Exact Sciences is the sole source capable of providing this critical test to predict chemotherapy benefit at the required level of quality.

The original solicitation was a pre-solicitation notice issued by the VA Strategic Acquisition Center - Frederick, announcing their intent to award this sole-source BPA to Exact Sciences Corporation. The applicable NAICS code is 621511 - Medical Laboratories, with a size standard of $41.5 million. The Product Service Code is Q301 - Medical - Laboratory Testing. The agency anticipates negotiating and awarding the BPA by July 15, 2024. No set-aside designation was used for this procurement, as Exact Sciences Corporation is the only source capable of providing the required Oncotype DX Breast Cancer Assay.

Task orders

Task order Ordering agency Obligated Awarded
VHA breast cancer molecular testing order 2 36C10X25F0038 VA Strategic Acquisition Center Frederick $1,481,749
VHA breast cancer molecular testing BPA 36C10X24F0099 VA Strategic Acquisition Center Frederick $438,653

Transactions

Action Obligated Date
Exercise an Option P00001 $0
Original award $0

Quick answers

Who was awarded contract 36C10X24A0011?

36C10X24A0011 was awarded to Exact Sciences Corporation by VA Strategic Acquisition Center Frederick (Headquarters) on September 1, 2024.

How much is contract 36C10X24A0011 worth?

Orders under 36C10X24A0011 have obligated $1,920,402. A single order can be worth up to $100,000.

How many orders have been placed under contract 36C10X24A0011?

2 orders have been placed under 36C10X24A0011, the latest on August 20, 2025.

Who can order from contract 36C10X24A0011?

36C10X24A0011 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36C10X24A0011 under another contract?

Yes. 36C10X24A0011 is a blanket purchase agreement under V797D70053, a federal supply schedule, on Medical Laboratory Testing and Analysis Services (FSS-621-II).

Was contract 36C10X24A0011 competed?

The extent of competition for 36C10X24A0011 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV